Literature DB >> 6499627

Relationship between clinical and laboratory parameters and length of lesion in Crohn's disease of small bowel.

C Prantera, C Luzi, P Olivotto, S Levenstein, P Cerro, A Fanucci.   

Abstract

The correlation of 22 commonly used clinical and laboratory abnormalities with linear extent of the lesion was studied in 70 patients with Crohn's ileitis, 16 of whom had inactive disease and 54 active disease. Extent was measured radiologically using a well-validated double-contrast technique. In the patients with active disease, lesion length was significantly correlated with weight loss, serum albumin, total protein, and serum iron. In the group without active inflammation, pain and abdominal mass were significantly correlated with lesion extent. No correlation was found between linear extent of lesion and the following: an index of inflammatory activity (New Crohn's Disease Activity Index), several acute-phase reactants, and the components of the complete blood count. Only total protein and serum iron had a significant regression coefficient following a procedure of stepwise regression. No mathematical model was found capable of satisfactorily predicting the length of lesion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6499627     DOI: 10.1007/bf01317082

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  9 in total

1.  The disease activity of ulcerative colitis and Crohn's disease.

Authors:  I Talstad; E Gjone
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

2.  A prospective study of the course of Crohn's disease.

Authors:  S Kaufman; B Chalmer; R Heilman; W Beeken
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

3.  Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study.

Authors:  P A Van Hees; H J Van Lier; P H Van Elteren; M Driessen; R A Van Hogezand; G P Ten Velde; J H Bakker; J H Van Tongeren
Journal:  Gut       Date:  1981-05       Impact factor: 23.059

4.  A simple index of Crohn's-disease activity.

Authors:  R F Harvey; J M Bradshaw
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

5.  Malabsorption of fat and vitamin B12 before and after intestinal resection for Crohn's disease.

Authors:  S Filipsson; L Hultén; G Lindstedt
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

6.  National Cooperative Crohn's Disease Study: results of drug treatment.

Authors:  R W Summers; D M Switz; J T Sessions; J M Becktel; W R Best; F Kern; J W Singleton
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

7.  A trial of sulfasalazine as adjunctive therapy in Crohn's disease.

Authors:  J W Singleton; R W Summers; F Kern; J M Becktel; W R Best; R N Hansen; D H Winship
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

8.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

9.  An index of inflammatory activity in patients with Crohn's disease.

Authors:  P A van Hees; P H van Elteren; H J van Lier; J H van Tongeren
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

  9 in total
  6 in total

1.  Predicting relapses of Crohn's disease. Clouds in the crystal ball.

Authors:  D B Sachar
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

2.  Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease.

Authors:  P Gomes; C du Boulay; C L Smith; G Holdstock
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

Review 3.  Technetium leukocyte imaging in inflammatory bowel disease.

Authors:  M Charron
Journal:  Curr Gastroenterol Rep       Date:  1999-06

4.  Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Authors:  C Cellier; T Sahmoud; E Froguel; A Adenis; J Belaiche; J F Bretagne; C Florent; M Bouvry; J Y Mary; R Modigliani
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

5.  Factors affecting plasma postheparin diamine oxidase activity.

Authors:  J S Thompson; D A Burnett; W P Vaughan
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

6.  Prediction of surgery for obstruction in Crohn's ileitis. A study of 64 patients.

Authors:  C Prantera; S Levenstein; R Capocaccia; S Mariotti; C Luzi; R Cosintino; M Simi
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.